Related Experiment Videos
Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells.
E J Goetzl1, S P Sreedharan, C W Turck
1Howard Hughes Medical Institute, University of California Medical Center, San Francisco 94143-0724.
The Journal of Biological Chemistry
|July 5, 1988
Summary
Researchers identified novel vasoactive intestinal peptide (VIP) variants in rat basophilic leukemia cells. These VIP peptides differ structurally from the known neuropeptide VIP, offering new insights into VIP signaling pathways.
Area of Science:
- Immunology
- Neuroendocrinology
- Cell Biology
Background:
- Vasoactive intestinal peptide (VIP) is a neuropeptide with diverse physiological roles.
- Rat basophilic leukemia (RBL) cells are a model system for studying mast cell degranulation and mediator release.
Purpose of the Study:
- To characterize the VIP-like peptides present in RBL cells.
- To determine the structure and release characteristics of these peptides.
Main Methods:
- Extraction and purification of peptides from RBL cells.
- Chromatographic techniques (Sephadex G-25, ion-exchange, reverse-phase HPLC).
- Antibody-based immunoassays and amino acid sequencing.
- Stimulation of RBL cells with ionophore A23187 to induce peptide release.
Main Results:
- Multiple immunoreactive VIP forms were detected in RBL cells, eluting at different volumes than standard VIP1-28.
- The smallest purified VIP peptide was identified as VIP10-28 with a modified C-terminus (asparagine-free acid).
- Ionophore A23187 rapidly released VIP10-28 from RBL cells.
Conclusions:
- RBL cells generate and release a mixture of VIP-related peptides.
- These peptides exhibit structural differences from the canonical neuropeptide VIP.
- The findings suggest a distinct VIP system within mast cells.